Skip to content

Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients

Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03592316
Enrollment
11
Registered
2018-07-19
Start date
2018-11-14
Completion date
2020-12-31
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Amputation

Brief summary

The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral amputations. A consecutive sample of patients diagnosed with peripheral vascular disease and/or diabetes requiring major lower extremity amputation will be enrolled in the study and compared to retrospective controls.

Interventions

OTHERLower Extremity Amputation Pathway

Pre-operatively: Subjects will meet with social work/case management, physical therapy, anesthesiology, and the prosthetist for the following: discuss expectations and rehabilitation; pain control options and consideration for epidural or nerve block; prosthetic treatment and care timeline. Post-operatively: Physical therapy will begin on post-op day 1 with increasing complexity through post-op day 3. On post-op day 3 the wound will be examined by the surgeon and subjects will be cleared for discharge. Quality of life surveys will be given at several time points during post-operative care.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \>18 years of age diagnosed with peripheral vascular disease and/or diabetes mellitus * Patients undergoing trans-tibial or trans-femoral amputations

Exclusion criteria

* Patients undergoing amputation for trauma, malignancy, or necrotizing fasciitis with no dysvascular diagnosis * Patients who have previously undergone an amputation * Patients who were unable to function independently prior to admission * Patients admitted to the ICU prior to surgery * Attending surgeon does not approve of the patient being enrolled * Prisoners * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Hospital length of stayThrough hospital discharge, approximately 3 days after surgeryThe total hospital length of stay for the lower extremity amputation admission

Secondary

MeasureTime frameDescription
MortalityUp to 6 months after surgeryMortality during the follow-up period
Major adverse limb eventUp to 6 months after surgeryHematoma, infection, ischemia, and/or need for revision of amputation
In-hospital morbidityThrough hospital discharge, approximately 3 days after surgeryCatheter Associated Urinary Tract Infection, Pneumonia, Deep Vein Thrmbosis, and/or Pulmonary Embolism
Return to functional independenceUp to 6 months after surgeryTime to return to functional independence at home

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026